Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma

Standard treatment for patients with high-risk neuroblastoma remains multimodal therapy including chemoradiation, surgical resection, and autologous stem cell rescue. Immunotherapy has demonstrated success in treating many types of cancers; however, its use in pediatric solid tumors has been limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Jingbo, Liu, Junquan, Jacobson, Jillian C., Clark, Rachael A., Lee, Sora, Liu, Li, An, Zhiqiang, Zhang, Ningyan, Chung, Dai H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757561/
https://www.ncbi.nlm.nih.gov/pubmed/36525420
http://dx.doi.org/10.1371/journal.pone.0277956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757561/
https://www.ncbi.nlm.nih.gov/pubmed/36525420
http://dx.doi.org/10.1371/journal.pone.0277956

Ejemplares similares